Pharmaceutical R&D at Work

  1. profile image0
    JaxsonRaineposted 5 years ago … ction.html

    A drug that reduces the probability of contracting HIV by 42-75%.

    As I've shown before, Americans are the ones who foot the bill for pharmaceutical R&D, by paying double what the rest of the OECD pays for the same pills.

    Gilead Sciences, the company that came out with the drug in 2004, spent $488 million on R&D in 2003, which was 56% of their total revenues.